Because of the tolerability and enhanced effectiveness of P-CABs, it is very likely that they will change the future of treatment of acid-related disorders.
NDMA was one of several nitrosamine impurities implicated in the massive recall of angiotensin II receptor blockers (ARBs) since last year.
Using an ELISA model, researchers have confirmed the high sensitivity and specificity of the monoclonal antibody Das-1 in detecting pancreatic cystic lesions (PCLs) with a risk for malignancy.
For large, protruding or poorly lifting lesions, researchers indicate endoscopic submucosal dissection may prove to be more efficacious.
Although the results of ESD were generally positive in managing Barrett’s neoplasia, procedural improvements are needed ESD is to replace piecemeal endoscopic mucosal resection.
Repeat per-oral endoscopic myotomy (POEM) procedures are safe and efficacious for patients with persistent symptoms following initial POEM in the management of achalasia.
The disease may manifest in patients with symptoms of chronic pain, difficulty swallowing, poor growth, malnutrition, and weight loss.
Of the roughly two-thirds of reports of swallowing problems that included age data, more than three-quarters (76.8 percent) involved adults aged 65 years or older.
A working group of 35 international experts released the ICARUS guidelines on the selection of patients with gastroesophageal reflux disease for antireflux surgery.
The FDA approved Keytruda for the treatment of patients with recurrent locally advanced or metastatic squamous cell carcinoma of the esophagus whose tumors express PD-L1 (CPS ≥10) as determined by an FDA-approved test
Obesity may not affect the success of peroral endoscopic myotomy in patients with achalasia.
Findings reveal new MII-pH-based score can effectively detect postprandial rumination in refractory GERD with persistent regurgitation with high sensitivity and specificity.